How big is the North America Insulin Pens Market?

The North America Insulin Pens Market size is expected to reach USD 11.99 billion in 2024 and grow at a CAGR of 4.87% to reach USD 14.87 billion by 2029. Read More

What is the current North America Insulin Pens Market size?

In 2024, the North America Insulin Pens Market size is expected to reach USD 11.99 billion. Read More

Who are the key players in North America Insulin Pens Market?

Novo Nordisk, Eli Lilly, Biocon, Sanofi and Medtronic are the major companies operating in the North America Insulin Pens Market. Read More

What years does this North America Insulin Pens Market cover, and what was the market size in 2023?

In 2023, the North America Insulin Pens Market size was estimated at USD 11.41 billion. The report covers the North America Insulin Pens Market historical market size for years: 2018, 2019, 2020, 2021, 2022 and 2023. The report also forecasts the North America Insulin Pens Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

North America Insulin Pens Market Share

Statistics for the 2023 & 2024 North America Insulin Pens market share, created by Mordor Intelligence™ Industry Reports. North America Insulin Pens share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of North America Insulin Pens Industry

The North American insulin pens market is moderately consolidated in nature due to the presence of a few major companies operating globally as well as regionally namely Novo Nordisk, Sanofi, Eli Lilly and Company, Biocon, etc. among others.